<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The infantile form of <z:e sem="disease" ids="C0017921" disease_type="Disease or Syndrome" abbrv="AMD">Pompe disease</z:e> drives children to <z:hpo ids='HP_0011420'>death</z:hpo> before the first year of life due to <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> and <z:hpo ids='HP_0002093'>respiratory insufficiency</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We present the seven-year follow-up experience with enzyme replacement therapy on a child with <z:e sem="disease" ids="C0017921" disease_type="Disease or Syndrome" abbrv="AMD">Pompe disease</z:e>, being the longest follow-up in the country </plain></SENT>
<SENT sid="2" pm="."><plain>The treatment was well tolerated without adverse reactions </plain></SENT>
<SENT sid="3" pm="."><plain>The echocardiographic and electrocardiographic parameters clearly improved during the first year and remain stable </plain></SENT>
<SENT sid="4" pm="."><plain>Motor milestones (like rolling over or sitting down without support) were initially achieved, but, after the third year were getting lost </plain></SENT>
<SENT sid="5" pm="."><plain>The average age of ventilator dependence was also delayed (16 months) </plain></SENT>
<SENT sid="6" pm="."><plain>The 7-year old patient remains alive with severe <z:hpo ids='HP_0003324'>generalized muscle weakness</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The child notably overcame the average age of survival and <z:hpo ids='HP_0003674'>onset</z:hpo> of ventilator dependence </plain></SENT>
<SENT sid="8" pm="."><plain>Although the cardiovascular improvement was clear, enzyme replacement therapy efficacy on skeletal muscle was limited in this patient </plain></SENT>
</text></document>